Abstract
The fallopian tubes are subjected to a variety of inflammatory and neoplastic lesions. Reactive changes secondary to inflammation may potentially mimic malignancy. Many reactive and benign conditions may also result in tubal narrowing or occlusion and are often the underlying causes of ectopic pregnancy. The tube is the most frequent site of an ectopic pregnancy but is rare for primary gestational trophoblastic diseases. The latter are usually secondary to a lesion from the corpus. Tubal hyperplasia is a poorly defined and overlapping entity; in many cases, they represent precursor lesions of tubal borderline or malignant lesions. Recent advances in genetic testing for BRCA mutations in high-risk families had led to the recognition of early carcinomas of the fallopian tube in prophylactic bilateral salpingo-oophorectomy specimens. Tubal intraepithelial carcinoma has become the topic of vigorous research in recent years, and this lesion, particularly when found in the fimbriae, is now recognized as the source some ovarian and peritoneal high-grade serous carcinomas. Secondary involvement of the tubes by ovarian carcinomas or those of other sites is more common than primary tubal carcinomas. The commonest primary carcinomas of the fallopian tube are of serous differentiation, followed by endometrioid and transitional cell. Mesenchymal tumors are rare. Benign and malignant tumors of the broad ligament are similar to those arising from the ovaries in many aspects. Identification of sites of origin may sometimes be difficult.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Keith LG, Berger GS, Edelman DA, Newton W, Fullan N, Bailey R, et al. On the causation of pelvic inflammatory disease. Am J Obstet Gynecol. 1984;149(2):215–24.
Honore LH. Salpingitis isthmica nodosa in female infertility and ectopic tubal pregnancy. Fertil Steril. 1978;29(2):164–8.
Majmudar B, Henderson 3rd PH, Semple E. Salpingitis isthmica nodosa: a high-risk factor for tubal pregnancy. Obstet Gynecol. 1983;62(1):73–8.
Jenkins CS, Williams SR, Schmidt GE. Salpingitis isthmica nodosa: a review of the literature, discussion of clinical significance, and consideration of patient management. Fertil Steril. 1993;60(4):599–607.
Lisa JR, Gioia JD, Rubin IC. Observations on the interstitial portion of the fallopian tube. Surg Gynecol Obstet. 1954;92(2):159–69.
Lisa JR, Rubin IC, Trinidad S. Further observations on ectopic endometrium of the fallopian tube. Surg Gynecol Obstet. 1956;103(4):469–74.
David MP, Ben-Zwi D, Langer L. Tubal intramural polyps and their relationship to infertility. Fertil Steril. 1981;35(5):526–31.
Rock JA, Parmley TH, King TM, Laufe LE, Su BS. Endometriosis and the development of tuboperitoneal fistulas after tubal ligation. Fertil Steril. 1981;35(1):16–20.
Stock RJ. Postsalpingectomy endometriosis: a reassessment. Obstet Gynecol. 1982;60(5):560–70.
Seidman JD. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol. 1996;15(1):1–9.
Groisman GM, Meir A. CD10 is helpful in detecting occult or inconspicuous endometrial stromal cells in cases of presumptive endometriosis. Arch Pathol Lab Med. 2003;127(8):1003–6.
Nogales FF, Martin F, Linares J, Naranjo R, Concha A. Myxoid change in decidualized scar endometriosis mimicking malignancy. J Cutan Pathol. 1993;20(1):87–91.
Seidman JD. Mucinous lesions of the fallopian tube. A report of seven cases. Am J Surg Pathol. 1994;18(12):1205–12.
Wong AK, Seidman JD, Barbuto DA, McPhaul LW, Silva EG. Mucinous metaplasia of the fallopian tube: a diagnostic pitfall mimicking metastasis. Int J Gynecol Pathol. 2011;30(1):36–40.
Giles A, Yoon J, Lindley R. Multifocal mucinous neoplasia of the female genital system. Histopathology. 1994;25(3):281–3.
Mikami Y, Kiyokawa T, Sasajima Y, Teramoto N, Wakasa T, Wakasa K, et al. Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia. Histopathology. 2009;54(2):184–91.
Egan AJ, Russell P. Transitional (urothelial) cell metaplasia of the fallopian tube mucosa: morphological assessment of three cases. Int J Gynecol Pathol. 1996;15(1):72–6.
Hampton HL, Huffman HT, Meeks GR. Extraovarian brenner tumor. Obstet Gynecol. 1992;79(5 (Pt 2)):844–6.
Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol. 2011;30(1):4–11.
Alvarado-Cabrero I, Navani SS, Young RH, Scully RE. Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas. Int J Gynecol Pathol. 1997;16(3):189–96.
Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE. Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol. 1999;72(3):367–79.
Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009;33(1):111–9.
Giordano G, D'Adda T, Brigati F, Lombardi M, Raboni S. A unique case of primary squamous carcinoma of the salpinx associated with serous carcinoma of the omentum: a pathological and molecular study. Int J Gynecol Pathol. 2010;29(6):533–8.
Mekni A, Doghri R, Bel Haj Salah M, Tounsi H, Chelly I, Khadija B, et al. Simultaneous squamous carcinoma involving the fallopian tube and the uterine cervix. Arch Gynecol Obstet. 2008;278(2):157–9.
Hibbard LT. Adnexal torsion. Am J Obstet Gynecol. 1985;152(4):456–61.
Bernardus RE, Van der Slikke JW, Roex AJ, Dijkhuizen GH, Stolk JG. Torsion of the fallopian tube: some considerations on its etiology. Obstet Gynecol. 1984;64(5):675–8.
Seidman JD, Sherman ME, Bell KA, Katabuchi H, O'Leary TJ, Kurman RJ. Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection? Int J Gynecol Pathol. 2002;21(2):101–7.
Ellsworth HS, Harris JW, McQuarrie HG, Stone RA, Anderson 3rd AE. Prolapse of the fallopian tube following vaginal hysterectomy. JAMA. 1973;;224(6):891–2.
Silverberg SG, Frable WJ. Prolapse of fallopian tube into vaginal vault after hysterectomy. Histopathology, cytopathology, and differential diagnosis. Arch Pathol. 1974;97(2):100–3.
Wheelock JB, Schneider V, Goplerud DR. Prolapsed fallopian tube masquerading as adenocarcinoma of the vagina in a postmenopausal woman. Gynecol Oncol. 1985;21(3):369–75.
Michal M, Rokyta Z, Mejchar B, Pelikan K, Kummel M, Mukensnabl P. Prolapse of the fallopian tube after hysterectomy associated with exuberant angiomyofibroblastic stroma response: a diagnostic pitfall. Virchows Arch. 2000;437(4):436–9.
Varnholt H, Otis CN, Nucci MR, Johari VP. Fallopian tube prolapse mimicking aggressive angiomyxoma. Int J Gynecol Pathol. 2005;24(3):292–4.
Cheung AN, Young RH, Scully RE. Pseudocarcinomatous hyperplasia of the fallopian tube associated with salpingitis. A report of 14 cases. Am J Surg Pathol. 1994;18(11):1125–30.
Yanai-Inbar I, Silverberg SG. Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment. Int J Gynecol Pathol. 2000;19(2):139–44.
Gonzalez FA, Waxman M. Ectopic pregnancy. A retrospective study of 501 consecutive patients. Diagn Gynecol Obstet. 1981;3(3):181–6.
Gonzalez FA, Waxman M. Ectopic pregnancy. A prospective study on differential diagnosis. Diagn Gynecol Obstet. 1981;3(2):101–9.
Budowick M, Johnson Jr TR, Genadry R, Parmley TH, Woodruff JD. The histopathology of the developing tubal ectopic pregnancy. Fertil Steril. 1980;34(2):169–71.
Muto MG, Lage JM, Berkowitz RS, Goldstein DP, Bernstein MR. Gestational trophoblastic disease of the fallopian tube. J Reprod Med. 1991;36(1):57–60.
Ober WB, Maier RC. Gestational choriocarcinoma of the fallopian tube. Diagn Gynecol Obstet. 1981;3(3):213–31.
Hassadia A, Kew FM, Tidy JA, Wells M, Hancock BW. Ectopic gestational trophoblastic disease: a case series review. J Reprod Med. 2012;57(7–8):297–300.
Fisher RA, Savage PM, MacDermott C, Hook J, Sebire NJ, Lindsay I, et al. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies. Gynecol Oncol. 2007;107(3):413–9.
Vang R, Gupta M, Wu LS, Yemelyanova AV, Kurman RJ, Murphy KM, et al. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol. 2012;36(3):443–53.
Nayar R, Snell J, Silverberg SG, Lage JM. Placental site nodule occurring in a fallopian tube. Hum Pathol. 1996;27(11):1243–5.
Campello TR, Fittipaldi H, O'Valle F, Carvia RE, Nogales FF. Extrauterine (tubal) placental site nodule. Histopathology. 1998;32(6):562–5.
Kouvidou C, Karayianni M, Liapi-Avgeri G, Toufexi H, Karaiossifidi H. Old ectopic pregnancy remnants with morphological features of placental site nodule occurring in fallopian tube and broad ligament. Pathol Res Pract. 2000;196(5):329–32.
Baergen RN, Rutgers J, Young RH. Extrauterine lesions of intermediate trophoblast. Int J Gynecol Pathol. 2003;22(4):362–7.
Gupta N, Mittal S, Misra R, Vimala N, Das AK. Placental site trophoblastic tumor originating in a tubal ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006;129(1):92–4.
Su YN, Cheng WF, Chen CA, Lin TY, Hsieh FJ, Cheng SP, et al. Pregnancy with primary tubal placental site trophoblastic tumor–a case report and literature review. Gynecol Oncol. 1999;73(2):322–5.
Parker A, Lee V, Dalrymple C, Valmadre S, Russell P. Epithelioid trophoblastic tumour: report of a case in the fallopian tube. Pathology. 2003;35(2):136–40.
Tziortziotis DV, Bouros AC, Ziogas VS, Young RH. Clear cell hyperplasia of the fallopian tube epithelium associated with ectopic pregnancy: report of a case. Int J Gynecol Pathol. 1997;16(1):79–80.
Milchgrub S, Sandstad J. Arias-Stella reaction in fallopian tube epithelium. A light and electron microscopic study with a review of the literature. Am J Clin Pathol. 1991;95(6):892–5.
Vang R, Barner R, Wheeler DT, Strauss BL. Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma. Int J Gynecol Pathol. 2004;23(3):223–33.
Zaytsev P, Taxy JB. Pregnancy-associated ectopic decidua. Am J Surg Pathol. 1987;11(7):526–30.
Tilden IL, Winstedt R. Decidual reactions in fallopian tubes: histologic study of tubal segments from 144 post-partum sterilizations. Am J Pathol. 1943;19(6):1043–55.
Mills SE, Fechner RE. Stromal and epithelial changes in the fallopian tube following hormonal therapy. Hum Pathol. 1980;11(5 Suppl):583–5.
Bartnik J, Powell WS, Moriber-Katz S, Amenta PS. Metaplastic papillary tumor of the fallopian tube. Case report, immunohistochemical features, and review of the literature. Arch Pathol Lab Med. 1989;113(5):545–7.
Saffos RO, Rhatigan RM, Scully RE. Metaplastic papillary tumor of the fallopian tube–a distinctive lesion of pregnancy. Am J Clin Pathol. 1980;74(2):232–6.
D'Adda T, Pizzi S, Bottarelli L, Azzoni C, Manni S, Giordano G. Metaplastic papillary tumor of the salpinx: report of a case using microsatellite analysis. Int J Gynecol Pathol. 2011;30(6):532–5.
Glazener CM, Loveden LM, Richardson SJ, Jeans WD, Hull MG. Tubo-cornual polyps: their relevance in subfertility. Hum Reprod. 1987;2(1):59–62.
Donnez J, Casanas-Roux F, Ferin J, Thomas K. Tubal polyps, epithelial inclusions, and endometriosis after tubal sterilization. Fertil Steril. 1984;41(4):564–8.
Kurman RJ, Vang R, Junge J, Hannibal CG, Kjaer SK, Shih IM. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol. 2011;35(11):1605–14.
Yanai-Inbar I, Siriaunkgul S, Silverberg SG. Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential? Int J Gynecol Pathol. 1995;14(2):107–13.
Zheng W, Wolf S, Kramer EE, Cox KA, Hoda SA. Borderline papillary serous tumour of the fallopian tube. Am J Surg Pathol. 1996;20(1):30–5.
Kayaalp E, Heller DS, Majmudar B. Serous tumor of low malignant potential of the fallopian tube. Int J Gynecol Pathol. 2000;19(4):398–400.
Ondic O, Kalis V, Sima R. Borderline papillary serous tumor of the fimbriated end of the fallopian tube with peritoneal implants. J Obstet Gynaecol Res. 2011;37(11):1702–5.
Abreu R, Dick M, Simoes Silva T, Mota F, Bettencourt E. Serous borderline tumor of the fallopian tube presented as an adnexal mass. Arch Gynecol Obstet. 2011;283(2):349–52.
Scully RE, Young RH, Clement PB. Tumors of the fallopian tube: histologic classification and cancer staging, epithelial and mixed epithelial-mesenchymal tumors. In: Rosai JS, Sobin LH, editors. Atlas of tumor pathology tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington DC: Armed Forces Institute of Pathology; 1988. p. 461–76.
Nordin AJ. Primary carcinoma of the fallopian tube: a 20-year literature review. Obstet Gynecol Surv. 1994;49(5):349–61.
Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Trope CG, Abeler VM. Carcinoma of the fallopian tube. Cancer. 2000;89(10):2076–84.
Eddy GL, Copeland LJ, Gershenson DM, Atkinson EN, Wharton JT, Rutledge FN. Fallopian tube carcinoma. Obstet Gynecol. 1984;64(4):546–52.
Goldman JA, Gans B, Eckerling B. Hydrops tubae profluens–symptom in tubal carcinoma. Obstet Gynecol. 1961;18:631–4.
Sedlis A. Primary carcinoma of the fallopian tube. Obstet Gynecol Surv. 1961;16:209–26.
Euscher ED, Silva EG, Deavers MT, Elishaev E, Gershenson DM, Malpica A. Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy. Am J Surg Pathol. 2004;28(9):1217–23.
Yeung HH, Bannatyne P, Russell P. Adenocarcinoma of the fallopian tubes: a clinicopathological study of eight cases. Pathology. 1983;15(3):279–86.
Matsushita H, Kodama S, Aoki Y, Tanaka K, Saito N. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer. Gynecol Obstet Invest. 1998;45(2):140–3.
Seeber J, Reimer D, Muller-Holzner E, Spizzo G, Sepp N, Wiesbauer P, et al. Fallopian tube cancer associated with paraneoplastic dermatomyositis – asymptomatic multivisceral exacerbated dermatomyositis mimicking recurrent widespread malignant disease: case report. Eur J Gynaecol Oncol. 2008;29(2):168–70.
Hellstrom AC. Primary fallopian tube cancer: a review of the literature. Med Oncol. 1998;15(1):6–14.
Hellstrom AC, Silfversward C, Nilsson B, Pettersson F. Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series. Int J Gynecol Cancer. 1994;4(6):395–400.
Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211(1):26–35.
Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34(3):433–43.
Kurman RJ, Shih IM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol. 2011;42(7):918–31.
Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, et al. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012;31(3):243–53.
Kuhn E, Kurman RJ, Sehdev AS, Shih IM. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012;31(5):416–22.
Visvanathan K, Vang R, Shaw P, Gross A, Soslow R, Parkash V, et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am J Surg Pathol. 2011;35(12):1766–75.
McCluggage WG, Soslow RA, Gilks CB. Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance. Histopathology. 2011;59(4):786–8.
Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol. 2011;30(5):417–24.
Jarboe EA, Miron A, Carlson JW, Hirsch MS, Kindelberger D, Mutter GL, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol. 2009;28(4):308–15.
Chen EY, Mehra K, Mehrad M, Ning G, Miron A, Mutter GL, et al. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J Pathol. 2010;222(1):110–6.
Laury AR, Ning G, Quick CM, Bijron J, Parast MM, Betensky RA, et al. Fallopian tube correlates of ovarian serous borderline tumors. Am J Surg Pathol. 2011;35(12):1759–65.
Navani SS, Alvarado-Cabrero I, Young RH, Scully RE. Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases. Gynecol Oncol. 1996;63(3):371–8.
Culton LK, Deavers MT, Silva EG, Liu J, Malpica A. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol. 2006;30(7):844–9.
Young RH. Neoplasms of the fallopian tube and broad ligament: a selective survey including historical perspective and emphasising recent developments. Pathology. 2007;39(1):112–24.
Koshiyama M, Konishi I, Yoshida M, Wang DP, Mandai M, Mori T, et al. Transitional cell carcinoma of the fallopian tube: a light and electron microscopic study. Int J Gynecol Pathol. 1994;13(2):175–80.
Jackson-York GL, Ramzy I. Synchronous papillary mucinous adenocarcinoma of the endocervix and fallopian tubes. Int J Gynecol Pathol. 1992;11(1):63–7.
Aoyama T, Mizuno T, Andoh K, Takagi T, Eimoto T. alpha-Fetoprotein-producing (hepatoid) carcinoma of the fallopian tube. Gynecol Oncol. 1996;63(2):261–6.
Cheung AN, So KF, Ngan HY, Wong LC. Primary squamous cell carcinoma of fallopian tube. Int J Gynecol Pathol. 1994;13(1):92–5.
Herbold DR, Axelrod JH, Bobowski SJ, Freel JH. Glassy cell carcinoma of the fallopian tube. A case report. Int J Gynecol Pathol. 1988;7(4):384–90.
Peters 3rd WA, Andersen WA, Hopkins MP, Kumar NB, Morley GW. Prognostic features of carcinoma of the fallopian tube. Obstet Gynecol. 1988;71(5):757–62.
Riska A, Leminen A. Updating on primary fallopian tube carcinoma. Acta Obstet Gynecol Scand. 2007;86(12):1419–26.
Rosen AC, Ausch C, Hafner E, Klein M, Lahousen M, Graf AH, et al. A 15-year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Eur J Cancer. 1998;34(11):1725–9.
Rosen AC, Klein M, Hafner E, Lahousen M, Graf AH, Reiner A. Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Obstet Invest. 1999;47(1):45–51.
Rosen AC, Reiner A, Klein M, Lahousen M, Graf AH, Vavra N, et al. Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Oncol. 1994;53(3):307–13.
Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the fallopian tube. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S145–60.
Deffieux X, Morice P, Thoury A, Camatte S, Duvillard P, Castaigne D. Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma. J Am Coll Surg. 2005;200(1):45–8.
di Re E, Grosso G, Raspagliesi F, Baiocchi G. Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol. 1996;62(2):199–202.
Klein M, Rosen A, Lahousen M, Graf A, Vavra N, Beck A, et al. Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol. 1994;55(3 Pt 1):336–8.
Klein M, Rosen AC, Lahousen M, Graf AH, Rainer A. Lymphadenectomy in primary carcinoma of the fallopian tube. Cancer Lett. 1999;147(1–2):63–6.
Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31(2):161–9.
Seidman JD, Zhao P, Yemelyanova A. “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol. 2011;120(3):470–3.
Colgan TJ. Challenges in the early diagnosis and staging of fallopian-tube carcinomas associated with BRCA mutations. Int J Gynecol Pathol. 2003;22(2):109–20.
Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, et al. A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol. 2001;80(3):341–5.
Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol. 2005;106(6):1327–34.
Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol. 2003;21(22):4222–7.
Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30(2):230–6.
Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005;23(1):127–32.
Agoff SN, Garcia RL, Goff B, Swisher E. Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations. Am J Surg Pathol. 2004;28(8):1112–4.
Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol. 2006;30(10):1222–30.
Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100(1):58–64.
Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol. 2009;22(9):1133–8.
Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto MG, Crum CP. Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol. 2006;13(1):1–7.
Youngs LA, Taylor HB. Adenomatoid tumors of the uterus and fallopian tube. Am J Clin Pathol. 1967;48(6):537–45.
Skinnider BF, Young RH. Infarcted adenomatoid tumor: a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty. Am J Surg Pathol. 2004;28(1):77–83.
Mondal SK. Adenofibroma and ectopic pregnancy of left fallopian tube: a rare coexistence. J Obstet Gynaecol Res. 2010;36(3):690–2.
Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87(1):52–6.
Agoff SN, Mendelin JE, Grieco VS, Garcia RL. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or −2 mutations: implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol. 2002;26(2):171–8.
Gollard R, Kosty M, Bordin G, Wax A, Lacey C. Two unusual presentations of mullerian adenosarcoma: case reports, literature review, and treatment considerations. Gynecol Oncol. 1995;59(3):412–22.
Hellström A-C, Auer G, Silfverswärd C, Pettersson F. Prognostic factors in malignant mixed Müllerian tumor of the fallopian tube: the Radiumhemmet series 1923–1994. Int J Gynecol Cancer. 1996;6(6):467–72.
Carlson Jr JA, Ackerman BL, Wheeler JE. Malignant mixed mullerian tumor of the fallopian tube. Cancer. 1993;71(1):187–92.
Imachi M, Tsukamoto N, Shigematsu T, Watanabe T, Uehira K, Amada S, et al. Malignant mixed Mullerian tumor of the fallopian tube: report of two cases and review of literature. Gynecol Oncol. 1992;47(1):114–24.
Weber AM, Hewett WF, Gajewski WH, Curry SL. Malignant mixed mullerian tumors of the fallopian tube. Gynecol Oncol. 1993;50(2):239–43.
Gagner JP, Mittal K. Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma. Gynecol Oncol. 2005;97(1):219–22.
Ben-Ami M, Battino S, Shalev E. Pregnancy following GnRH agonist therapy of uterine leiomyoma obstructing a single fallopian tube. Hum Reprod. 1993;8(5):780–1.
Misao R, Niwa K, Iwagaki S, Shimokawa K, Tamaya T. Leiomyoma of the fallopian tube. Gynecol Obstet Invest. 2000;49(4):279–80.
Mroueh J, Margono F, Feinkind L. Tubal pregnancy associated with ampullary tubal leiomyoma. Obstet Gynecol. 1993;81(5 (Pt 2)):880–2.
Jacoby AF, Fuller Jr AF, Thor AD, Muntz HG. Primary leiomyosarcoma of the fallopian tube. Gynecol Oncol. 1993;51(3):404–7.
Buchwalter CL, Jenison EL, Fromm M, Mehta VT, Hart WR. Pure embryonal rhabdomyosarcoma of the fallopian tube. Gynecol Oncol. 1997;67(1):95–101.
Mitsuhashi A, Nagai Y, Suzuka K, Yamazawa K, Nojima T, Nikaido T, et al. Primary synovial sarcoma in fallopian tube: case report and literature review. Int J Gynecol Pathol. 2007;26(1):34–7.
Halligan AW, McGuinness EP. Malignant fibrous histiocytoma of the fallopian tube. Br J Obstet Gynaecol. 1990;97(3):275–6.
Foster R, Solano S, Mahoney J, Fuller A, Oliva E, Seiden MV. Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. Gynecol Oncol. 2006;101(2):363–6.
Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984;53(9):1978–84.
Snyder MJ, Bentley R, Robboy SJ. Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis. Int J Gynecol Pathol. 2006;25(2):155–60.
Pins MR, Young RH, Crum CP, Leach IH, Scully RE. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol. 1997;16(3):272–8.
Dos Santos LA, Garg K, Diaz JP, Soslow RA, Hensley ML, Alektiar KM, et al. Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma. Gynecol Oncol. 2011;121(2):319–22.
Samaha M, Woodruff JD. Paratubal cysts: frequency, histogenesis, and associated clinical features. Obstet Gynecol. 1985;65(5):691–4.
Kariminejad MH, Scully RE. Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity. Cancer. 1973;31(3):671–7.
Rahilly MA, Williams AR, Krausz T, al Nafussi A. Female adnexal tumour of probable Wolffian origin: a clinicopathological and immunohistochemical study of three cases. Histopathology. 1995;26(1):69–74.
Ramirez PT, Wolf JK, Malpica A, Deavers MT, Liu J, Broaddus R. Wolffian duct tumors: case reports and review of the literature. Gynecol Oncol. 2002;86(2):225–30.
Daya D. Malignant female adnexal tumor of probable wolffian origin with review of the literature. Arch Pathol Lab Med. 1994;118(3):310–2.
Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum Pathol. 1999;30(7):856–63.
Tiltman AJ, Allard U. Female adnexal tumours of probable Wolffian origin: an immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives. Histopathology. 2001;38(3):237–42.
Aydin H, Young RH, Ronnett BM, Epstein JI. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma. Am J Surg Pathol. 2005;29(4):520–3.
Gersell DJ, King TC. Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease. Am J Surg Pathol. 1988;12(2):145–9.
Korn WT, Schatzki SC, DiSciullo AJ, Scully RE. Papillary cystadenoma of the broad ligament in von Hippel-Lindau disease. Am J Obstet Gynecol. 1990;163(2):596–8.
Werness BA, Guccion JG. Tumor of the broad ligament in von Hippel-Lindau disease of probable mullerian origin. Int J Gynecol Pathol. 1997;16(3):282–5.
Clarke BA, Rahimi K, Chetty R. Leiomyosarcoma of the broad ligament with osteoclast-like giant cells and rhabdoid cells. Int J Gynecol Pathol. 2010;29(5):432–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Ip, P.P.C., Cheung, A.N.Y. (2014). Pathology of the Fallopian Tube. In: Wilkinson, N. (eds) Pathology of the Ovary, Fallopian Tube and Peritoneum. Essentials of Diagnostic Gynecological Pathology. Springer, London. https://doi.org/10.1007/978-1-4471-2942-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2942-4_17
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2941-7
Online ISBN: 978-1-4471-2942-4
eBook Packages: MedicineMedicine (R0)